High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine
Article in Frontiers in Cardiovascular Medicine (October 2023)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
3,5-T2-an Endogenous Thyroid Hormone Metabolite as Promising Lead Substance in Anti-Steatotic Drug Development?
Article in Metabolites (June 2022)
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease
Article in Frontiers in Pharmacology (April 2020)